Moderna announced Tuesday it has officially filed for the full FDA approval of the Covid-19 vaccine according to Local Syracuse.
Currently, Moderna’s Covid-19 vaccine is only approved for emergency use in the United States.
This announcement comes weeks after Pfizer and BioNTech sought full approval for their vaccine in the United States.
Moderna’s current contract with the United States agrees to provide 300 million doses of its vaccine. More that 151 million doses have been distributed in the United States and 124.5 have been administered as of Monday.
In April, Moderna’s vaccine showed an efficacy rate of more than 90% against all cases of Covid-19 in people 6 months after receiving the shot, and a 95% efficacy rate against severe Covid-19.
- New York extends $5 million ‘Vax & Scratch’ lottery another week
- Teens who get vaccinated will be entered for full-scholarships to SUNY, CUNY schools
- Billions available for renters, small businesses across New York now
- Legal experts say it will become more difficult to remain unvaccinated as time goes on, COVID rules shift
The FDA recently authorized changes to Moderna’s vaccine to allow up to 11 doses per vial when it was previously 10. It was also approved for vials to now hold up to 15 doses. These changes will be added in the instructions for healthcare workers administering the vaccine.

